The global pharmaceutical industry has been subjected to many challenges in the last decade, including more blockbuster drugs reaching the end of their patent life, increased regulation, pricing pressure, channel pressure, counterfeiting, and challenges in clinical trials management. This book covers the major themes and changes in the biopharmaceutical supply chain. It provides an overview of the key challenges and discusses how leading biopharma companies are dealing with these challenges. Bringing together leading researchers and industry executives, it is a must-read for those who want to learn more about achieving success in this industry.